Deb Autor

Non Executive Director at hims & hers in November 2024 to Present

Chief Executive Officer at Healthcare Innovation Catalysts in January 2024 to Present

Non Executive Director at Pardes Biosciences in July 2021 to August 2023

Scientific Advisory Council Member at CIRS - Centre for Innovation in Regulatory Science, Ltd in January 2020 to December 2021

Global Head of Regulatory Excellence at AstraZeneca in September 2019 to December 2021

Advisory Board Member, Quality Institute at US Pharmacopeia in January 2017 to January 2019

Board Member at AMR Industry Alliance in January 2018 to January 2019

Head of Strategic Global Quality & Regulatory Policy at Mylan in January 2016 to January 2019

Board Member at PDA - Parenteral Drug Association in January 2015 to January 2018

Global Head of Quality at Mylan in January 2013 to January 2016

Deputy Commissioner, Global Regulatory Operations and Policy at FDA in January 2011 to January 2013

Director and Associate Director, Office of Compliance, Center for Drug Evaluation and Research at FDA in January 2001 to January 2011

Trial Attorney, Office of Consumer Litigation at U.S. Department of Justice in January 1995 to January 2001

Associate at Weil, Gotshal & Manges and Buc Levitt & Beardsley in January 1992 to January 1995